WCN26-9147 PGNMID with AKI Successfully Managed by Clone-Directed Therapy

Read full text Summarise with VIRAT
Authors: Shohei Maekawa, Shinya Yamamoto, Motoko Yanagita
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is a rare glomerulonephritis, accounting for only 0.2% of native kidney biopsies. It results from monoclonal immunoglobulin deposition due to clonal plasma or B-cell proliferation, leading to glomerular injury. The clinical manifestations of PGNMID encompass proteinuria, hematuria, and renal impairment, which typically progress chronically in the absence of appropriate treatment. However, acute deterioration of kidney function necessitating dialysis is infrequent during the course of PGNMID.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Multiple Myeloma Research and Treatments Vasculitis and related conditions

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105832–105832
Publication date
25 March 2026
Language
EN